264 related articles for article (PubMed ID: 10810178)
1. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 1999 Jun; 64(6):631-5. PubMed ID: 10395976
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2001 Jun; 66(6):658-61. PubMed ID: 11421815
[TBL] [Abstract][Full Text] [Related]
4. [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets].
Muzia GI; Kulikov VI
Biokhimiia; 1996 Mar; 61(3):455-60. PubMed ID: 8724603
[TBL] [Abstract][Full Text] [Related]
5. [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators].
Kulikov VI; Muzia GI
Biokhimiia; 1992 Jun; 57(6):803-16. PubMed ID: 1420585
[TBL] [Abstract][Full Text] [Related]
6. 1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen.
Hornby EJ; Perry CR
Thromb Haemost; 1983 Aug; 50(2):586-7. PubMed ID: 6636035
[TBL] [Abstract][Full Text] [Related]
7. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
[TBL] [Abstract][Full Text] [Related]
8. 1-O-hexadec-1'-enyl-2-acetyl-sn-glycero-3-phosphocholine and its biological activity.
Nakayama R; Yasuda K; Satouchi K; Saito K
Biochem Biophys Res Commun; 1988 Mar; 151(3):1256-61. PubMed ID: 3355555
[TBL] [Abstract][Full Text] [Related]
9. Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
Hwang SB; Wang S
Mol Pharmacol; 1991 Jun; 39(6):788-97. PubMed ID: 2051992
[TBL] [Abstract][Full Text] [Related]
10. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
Vargaftig BB; Joseph D; Marlas G; Chevance LG
Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
[TBL] [Abstract][Full Text] [Related]
11. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions.
Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J
Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414
[TBL] [Abstract][Full Text] [Related]
12. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
Wal F; Joseph D; Touqui L; Vargaftig BB
Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
[TBL] [Abstract][Full Text] [Related]
14. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
[TBL] [Abstract][Full Text] [Related]
15. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
[TBL] [Abstract][Full Text] [Related]
17. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
Ostermann G; Kertscher HP; Till U
Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829
[TBL] [Abstract][Full Text] [Related]
18. A novel CoA-independent transacetylase produces the ethanolamine plasmalogen and acyl analogs of platelet-activating factor (PAF) with PAF as the acetate donor in HL-60 cells.
Lee TC; Uemura Y; Snyder F
J Biol Chem; 1992 Oct; 267(28):19992-20001. PubMed ID: 1400315
[TBL] [Abstract][Full Text] [Related]
19. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Porta C; Maiolo A; Tua A; Grignani G
Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
[TBL] [Abstract][Full Text] [Related]
20. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium.
Yi FX; Guo ZG
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
